A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993).
暂无分享,去创建一个
M. Piccart | L. Mauriac | L. Dirix | P. Canney | P. Chollet | C. Dittrich | R. Coleman | L. Biganzoli | V. Batter | E. Ngalula-Kabanga